FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma

Objective: This study aimed to validate FANCI as a potential marker for both prognosis and therapy in liver hepatocellular carcinoma. Method: FANCI expression data were acquired from GEPIA, HPA, TCGA, and GEO databases. The impact of clinicopathological features was analyzed by UALCAN. The prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yibo, Li, Jianing, Yu, Albert, Deng, Kexin, Chen, Jiawei, Wang, Zixian, Huang, Laiqiang, Ma, Shaohua, Dai, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266051/
https://www.ncbi.nlm.nih.gov/pubmed/37324186
http://dx.doi.org/10.7150/ijms.83760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266051/
https://www.ncbi.nlm.nih.gov/pubmed/37324186
http://dx.doi.org/10.7150/ijms.83760

Ejemplares similares